SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-331406
Filing Date
2017-11-03
Accepted
2017-11-02 18:14:33
Documents
4
Period of Report
2017-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d488842d8k.htm 8-K 26369
2 EX-1.1 d488842dex11.htm EX-1.1 151816
3 EX-5.1 d488842dex51.htm EX-5.1 5788
4 EX-99.1 d488842dex991.htm EX-99.1 7671
  Complete submission text file 0001193125-17-331406.txt   192817
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 171174011
SIC: 2835 In Vitro & In Vivo Diagnostic Substances